Stay informed with the latest litigation news. Explore now
A Pharmaceutical Composition Comprising Metamizole, Drotaverine, And Caffeine - EP3749286B1
EP3749286
- Application Number
- EP19702616A
- Filing Date
- Feb 2, 2019
- Status
- Granted And Under Opposition
- Sep 19, 2024
- Grant Date
- Oct 23, 2024
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP3749286B1 was granted to Adamed Pharma on Oct 23, 2024 following the initial filing on Feb 2, 2019 under the application number EP19702616A . The current legal status of the patent is Granted And Under Opposition.
Patent Summary
Patent Family New
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents